Okyo Pharma Limited ADR (OKYO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | OKYO | AMGN | VRTX | REGN | GILD |
| Company | Okyo Pharma Limited ADR | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.1500 | 313.34 | 467.94 | 1,047.11 | 68.63 |
| High | 1.2800 | 319.00 | 478.96 | 1,069.69 | 69.99 |
| Low | 1.1500 | 311.45 | 467.86 | 1,045.00 | 68.50 |
| Last | 1.1900 | 311.45 | 470.88 | 1,049.64 | 68.62 |
| Change | unch | -1.00 | +2.16 | -1.39 | +0.01 |
| % Change | unch | -0.32% | +0.46% | -0.13% | +0.01% |
| Volume | 3,321 | 608,655 | 388,131 | 180,064 | 2,467,790 |
| 20-Day Average Volume | 8,987 | 2,418,930 | 1,309,663 | 474,008 | 9,365,317 |
| Previous Close | 1.1900 | 312.45 | 468.72 | 1,051.03 | 68.61 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.2856 | 307.60 | 475.67 | 1,031.77 | 66.28 |
| 20-Day Raw Stochastic | 28.21% | 53.41% | 53.83% | 71.20% | 64.56% |
| 20-Day Relative Strength | 42.07% | 56.79% | 59.26% | 65.23% | 55.92% |
| Weighted Alpha | -28.86 | +36.96 | +40.71 | +48.76 | -9.66 |
| Today's Opinion | 100% Sell | 100% Buy | 88% Buy | 100% Buy | 40% Sell |
| Previous Opinion | 100% Sell | 100% Buy | 88% Buy | 100% Buy | 56% Sell |
| Last Month's Opinion | 88% Sell | 72% Buy | 88% Buy | 72% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.83% since 06/24/24 | -2.01% since 06/24/24 | -0.76% since 06/24/24 | -1.13% since 06/24/24 | -2.71% since 06/24/24 |
| Low | 1.0900 on 06/25/24 | 310.59 on 06/28/24 | 467.67 on 06/28/24 | 1,041.78 on 06/28/24 | 68.06 on 06/28/24 |
| High | 1.2800 on 07/01/24 | 326.12 on 06/25/24 | 483.92 on 06/25/24 | 1,081.17 on 06/25/24 | 71.48 on 06/25/24 |
| 1-Month | |||||
| %Chg | -19.46% since 05/31/24 | +1.93% since 05/31/24 | +3.51% since 05/31/24 | +7.31% since 05/31/24 | +7.07% since 05/31/24 |
| Low | 1.0900 on 06/25/24 | 295.30 on 06/13/24 | 453.73 on 06/03/24 | 979.26 on 06/03/24 | 62.69 on 06/18/24 |
| High | 1.4800 on 06/12/24 | 326.12 on 06/25/24 | 486.42 on 06/07/24 | 1,081.17 on 06/25/24 | 72.18 on 06/21/24 |
| 3-Month | |||||
| %Chg | -18.37% since 04/01/24 | +10.15% since 04/01/24 | +12.09% since 04/01/24 | +8.51% since 04/01/24 | -5.58% since 04/01/24 |
| Low | 1.0900 on 06/25/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 1.5800 on 05/17/24 | 326.12 on 06/25/24 | 486.42 on 06/07/24 | 1,081.17 on 06/25/24 | 72.85 on 04/02/24 |
| 6-Month | |||||
| %Chg | -32.20% since 12/29/23 | +8.24% since 12/29/23 | +15.84% since 12/29/23 | +19.76% since 12/29/23 | -15.05% since 12/29/23 |
| Low | 1.0900 on 06/25/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 871.39 on 01/02/24 | 62.07 on 05/31/24 |
| High | 1.9500 on 01/08/24 | 329.72 on 02/05/24 | 486.42 on 06/07/24 | 1,081.17 on 06/25/24 | 87.86 on 01/19/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 34,310 | 167,609,120 | 120,954,608 | 115,808,784 | 85,477,984 |
| Shares Outstanding, K | 28,832 | 536,435 | 258,053 | 110,186 | 1,245,853 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 27,116,000,000 |
| Annual Net Income | -13,270,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 5,665,000,000 |
| Last Quarter Sales | N/A | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 6,686,000,000 |
| Last Quarter Net Income | N/A | -113,000,000 | 1,099,600,000 | 722,000,000 | -4,170,000,000 |
| 60-Month Beta | 0.03 | 0.60 | 0.41 | 0.13 | 0.20 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -1.32 on 04/25/24 |
| Latest Earnings Date | 08/20/24 | 08/01/24 | 08/06/24 | 08/01/24 | 08/01/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.770 on 06/14/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 06/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.84 | 31.38 | 28.32 | 17.08 |